Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.

Langenbeck's archives of surgery - 1 Apr 2012

Grade Marian, Wolff Hendrik A, Gaedcke Jochen, Ghadimi B Michael

Abstract excerpt

INTRODUCTION: Preoperative chemoradiotherapy represents the standard treatment for patients with locally advanced rectal cancer. Unfortunately, the response of individual tumors to multimodal treatment is not uniform and ranges from complete response to complete resistance. This poses a particula...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy
Share to Combined Modality Therapy
Share to DNA Damage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoadjuvant Therapy

Share to Precision Medicine

Share to Radiation Tolerance

Share to Rectal Neoplasms

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 22382702
DOI: 10.1007/s00423-012-0929-5
PMCID: PMC3314820

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22382702-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.PMID 22382702Read ↗

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Semantic proximity Read ↗

Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.Semantic proximity Read ↗

Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancerSemantic proximity Read ↗

Gene expression profile is associated with chemoradiation resistance in rectal cancerSemantic proximity Read ↗

Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omicsSemantic proximity Read ↗

KRASG12V/A146T mutations are associated with nCRT resistance via enhanced DNA double-strand break repair and support a deep learning prediction framework in LARC.Semantic proximity Read ↗

Recent advances in personalized colorectal cancer research.Semantic proximity Read ↗

Leveraging a Patient-Derived Tumoroid Platform for Precision Radiotherapy: Uncovering DNA Damage Repair Inhibitor-Mediated Radiosensitization and Therapeutic Resistance in Rectal CancerSemantic proximity Read ↗

Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer.Semantic proximity Read ↗

Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.Semantic proximity Read ↗

Rectal cancer and importance of chemoradiation in the treatment.Semantic proximity Read ↗

Rectal cancer sub-clones respond differentially to neoadjuvant therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.